Navigation Links
PSI Corp. Announces Additional Hospitals and Medical Office Buildings to Utilize Its Digital Signage Network
Date:4/28/2008

NEW YORK, April 28 /PRNewswire-FirstCall/ -- PSI Corp. (Pink Sheets: PSCP) is announcing that Hospital Media Network (HMN), its partner in the Digital Signage Network, has signed additional facilities which will utilize the PSI Digital Signage Network.

David Foni, Chairman and CEO of PSI Corp. stated, "These additional locations in South Carolina and Texas are accretive to PSI's network in more than just additional revenue. These new facilities will permit PSI's advertisers to communicate to patients, visitors and staff outside of PSI's New York City existing locations."

David Foni further said, "What is equally good news is that HMN has successfully signed on different types of advertisers whose ads will run on the New York City Hospitals starting May 1."

Christopher Culver, CEO of HMN added, "The Hospitals and Medical Office Buildings in South Carolina and Texas is just the beginning. HMN has a number of additional proposals for PSI's Digital Signage Network being reviewed currently. I believe that expansion of the network will continue at a brisk cadence."

About PSI Corp.: provides interactive customer communications systems and applications that support the targeted marketing programs at point-of-purchase (POP) service and information. The company has two vertical products: full motion video digital signage and full service Cash Express(TM) Kiosks/ATM. For more information please visit the company website: http://www.pantelsystems.com

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made on behalf of the Company and its subsidiaries. All such forward-looking statements are, by necessity, only estimates of future results and actual results achieved by the Company may differ materially from these statements due to a number of factors. Any forward-looking statements speak only as of the date made. Statements made in this release that are not purely historical are forward-looking statements, beliefs, plans, expectations or intentions regarding the future. Risk factors that may cause results to differ from projections include, without limitation, loss of suppliers, loss of customers, inadequate capital, competition, loss of key executives, declining prices, and other economic factors. The Company assumes no obligations to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. Investors should independently investigate and fully understand all risks before making investment decisions.

For further Information:

David Foni (719) 359-5533


'/>"/>
SOURCE PSI Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
2. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
3. Oracle Healthcare Acquisition Corp. Changes Record Date and Date of Special Meeting to Consider and Vote on Dissolution and Plan of Liquidation
4. Eurosport Active World, Corp. Announces Reverse Merger Into Eagle International Holdings Group, Inc.
5. SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
6. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
7. Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations
8. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
9. CVS Caremark Corp. to Pay $36.7 Million to U.S., 23 States, & D.C. to Settle Medicaid Prescription Drug Fraud Allegations
10. HMS Holdings Corp. to Present at Bank of America 2008 SmidCap Conference
11. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: